– Reuters
“Vaccinex Has Received A Notice Of Allowance For Its U.S. Patent Application 17/352,574 Titled ‘Use Of Semaphorin-4D Binding Molecules For The Treatment Of Rett Syndrome'”
https://patentcenter.uspto.gov/applications/17352574/ifw/docs